NEW YORK, August 3, 2026, 14:10 EDT – Hydrofarm NASDAQ:HYFM shares soared 289% after the company announced it sold assets worth $16 million, while its substantial debt continues to be a key challenge.
- Shares of Hydrofarm rose 288.9% to $2.10, with 120.1 million shares changing hands.
- The sale of Aurora Peat totals $16 million in consideration, with a $5 million note included.
- March filings indicated a term loan of $114.4 million and an equity shortfall of $78.1 million.
Hydrofarm stock jumped 288.9% to $2.10 as of 14:01 EDT Monday, with U.S. exchanges open. The increase came after finalization of the Aurora Peat sale.
The relevant ratio stands at six to one. The market capitalization on Friday reached approximately $2.57 million. The disclosed deal amount was 6.2 times greater. As of March, the term-loan principal totaled $114.4 million.
The response was limited to the company. Two similar companies in the sector recorded gains in the low single digits.
| Company | Price | Monday change | Market value |
|---|---|---|---|
| Hydrofarm NASDAQ:HYFM | $2.10 | up 288.9% | $10.0 million |
| GrowGeneration NASDAQ:GRWG | $1.47 | higher by 2.1% | $88.3 million |
| Scotts Miracle-Gro (NYSE:SMG) | $67.85 | rose 3.3% | $4.01 billion |
Prices shown reflect intraday levels as of approximately 14:00 EDT. Percentage changes are based on these reported prices and their movement within the session.
Hydrofarm has divested Aurora Peat, selling it to Raven Holdings, a private entity, for a total of $16 million. The deal includes a $5 million promissory note. CEO Bill Toler described the move as “a key strategic step toward optimizing our portfolio and focus, and strengthening the Company’s capital structure.” GlobeNewswire
The deal appears significant compared to equity, but is less so when compared to debt.
| Reference base | Amount | $16 million consideration | $11 million implied non-note amount |
|---|---|---|---|
| Friday market value | $2.57 million | 6.2 times | 4.3 times |
| Current market value | $10.01 million | 1.6 times | 1.1 times |
| March cash | $4.8 million | 3.3 times | 2.3 times |
| March term loan | $114.4 million | 14.0% | 9.6% |
The $11 million non-note figure is an initial calculation. It does not include fees, taxes, or other modifications. Friday’s market value is based on approximately 4.76 million shares at a closing price of $0.54.
If the entire $11 million is applied to the principal, the term loan drops to roughly $103.4 million. This remains 10.3 times the present market value. Paying down debt by itself does not alter equity. Any improvement would rely on the gain from the transaction.
The operating base was fragile ahead of Monday’s agreement.
| First-quarter measure | 2026 | 2025 | Change |
|---|---|---|---|
| Net sales | $28.5 million | $40.5 million | down 29.6% |
| GAAP gross margin | 6.4% | 17.0% | decreased by 10.6 percentage points |
| SG&A expense | $10.6 million | $17.9 million | down 40.8% |
| Adjusted EBITDA | -$3.9 million | -$2.4 million | Loss increased by $1.5 million |
| Free cash flow | -$0.8 million | -$12.0 million | Improved by $11.2 million |
Adjusted EBITDA and free cash flow refer to non-GAAP metrics defined by the company. Results represent performance for the quarter ended March 31.
Cost reductions were tangible but failed to counteract declines in volume and reduced efficiency at factories. Free cash flow saw a significant improvement, but stayed in negative territory.
Project Agility reallocates resources to expand logistics services in neighboring industries. Management noted that logistics currently represents a minor portion of overall performance. No specific targets were provided for revenue, margins or capital.
The Nasdaq risk is distinct. Hydrofarm disclosed in its most recent 8-K that it has appealed a decision for delisting related to an equity rule. The appeal pauses any additional steps while the hearing is underway.
| Nasdaq test | Requirement | Hydrofarm snapshot | Distance or status |
|---|---|---|---|
| Stockholders’ equity | At least $2.5 million | -$78.1 million | $80.6 million below |
| Market value of listed securities | At least $35 million | About $10.0 million | Roughly $25 million under |
| Net-income alternative | $0.5 million in latest year, or two of three | 2025 loss: $289.8 million; 2024 loss: $66.7 million | Does not qualify for those periods |
| Minimum closing bid | At least $1 | $2.10 intraday | Needs ten straight sessions at the minimum |
Market capitalization is measured using current value as an estimated market-value indicator. Official calculation and compliance assessment are governed by Nasdaq.
The equity approach requires an $80.6 million boost compared to March figures. Gross consideration covers just around 20% of this shortfall. The precise impact is determined by book value, expenses, and liabilities that change hands. Based on market value, the figure is close to $7.35 per share.
Trading dynamics intensified the swing. By 14:01, volume hit 120.1 million shares—roughly 25 times the number of shares outstanding and 34 times the reported float. The stock retreated from an opening price of $3.11.
Risks are still significant. The $5 million note involves collection risk. Hydrofarm disclosed a term-loan default and negative equity. Sales and margins are declining. Nasdaq listing remains unresolved. The turnover brings reversal risk.
Hydrofarm has yet to reveal Aurora Peat’s book value, transaction expenses, terms of the note or details of the logistics economics. These data points are required for a pro forma equity analysis.
